semaglutide after kidney transplant and Survival Outcomes with by... : Clinical Journal of the American Society of Nephrology Anti-Obesity Drugs Benefit Kidney Transplant

Liraglutide: a human GLP-1 analog for type 2 diabetes

STAY SHARP, STAY DRIVEN: Dieting is mental

Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A

Diabetes Obes Metab (2018) 20(Suppl 2):8894

Ischaemic stroke

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist designed to bind to GLP-1 receptors, which help regulate appetite.[4] Semaglutide was originally developed as a treatment for T2D to improve blood sugar levels, but clinical trials later showed that patients also lost weight while taking it.[4-8] Additional studies support semaglutides effectiveness in promoting weight loss in non-diabetics.[5,8,11] Semaglutide supports weight loss by suppressing appetite, delaying stomach emptying, and stimulating insulin secretion.[4] It is typically used alongside dietary changes and exercise in adults with and without diabetes.[4] All GLP-1 medications require a prescription from a healthcare provider